← Insider buys
KITE

Kite Pharma, Inc.

EVP, Business Development Helen Susan Kim sold $2.9M of Kite Pharma, Inc.

Sold$2,912,272
$109.28Price
26,649Shares
−59%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Mon, Jul 31. Filed Tue, Aug 1, 3:00 PM ET, during the session. Not investment advice.